The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility
- PMID: 2266154
- DOI: 10.1093/oxfordjournals.humrep.a137189
The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility
Abstract
Sixteen patients with polycystic ovarian syndrome (PCO) were treated by in-vitro fertilization (26 treatment cycles). The results were compared with 37 normo-ovulatory women with tubal disease (37 treatment cycles). The oestradiol and progesterone levels were higher during the follicular phase in the PCO patients, but were statistically significantly higher only on the day after human chorionic gonadotrophin administration. Although more oocytes were recovered per cycle from the PCO group (19.3 +/- 6.1) than from the control group (5.4 +/- 2.9) with P less than 0.004, the mean numbers of embryos per cycle were similar in both groups (3.7 +/- 2.4 versus 3.6 +/- 2.2, respectively). The pregnancy rate was also comparable in both groups (30.7 versus 29.7%, respectively). The fact that more oocytes are recovered from PCO patients, balances their lower fertilization and cleavage rates. We conclude, therefore, that IVF treatment may be a viable solution for PCO patients resistant to an in-vivo protocol treatment regimes.
Similar articles
-
Polycystic ovarian disease (PCOD)--pregnancy rate and outcome in in vitro fertilization.J Assist Reprod Genet. 1993 Jan;10(1):11-4. doi: 10.1007/BF01204434. J Assist Reprod Genet. 1993. PMID: 8499673 Review. No abstract available.
-
Total renin after gonadotropin stimulation in polycystic ovarian disease.Fertil Steril. 1995 Feb;63(2):307-13. doi: 10.1016/s0015-0282(16)57361-0. Fertil Steril. 1995. PMID: 7843437
-
Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility.Hum Reprod. 2001 Dec;16(12):2587-92. doi: 10.1093/humrep/16.12.2587. Hum Reprod. 2001. PMID: 11726579
-
Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome.Hum Reprod. 1999 Mar;14(3):601-5. doi: 10.1093/humrep/14.3.601. Hum Reprod. 1999. PMID: 10221682
-
Adverse effects of luteinizing hormone on fertility: fact or fantasy.Baillieres Clin Obstet Gynaecol. 1998 Dec;12(4):555-63. doi: 10.1016/s0950-3552(98)80051-5. Baillieres Clin Obstet Gynaecol. 1998. PMID: 10627767 Review.
Cited by
-
Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study.J Assist Reprod Genet. 2015 Jul;32(7):1031-42. doi: 10.1007/s10815-015-0488-0. Epub 2015 May 1. J Assist Reprod Genet. 2015. PMID: 25925351 Free PMC article.
-
In vitro fertilization cycle and embryo transfer outcomes in oligoanovulatory patients with hypothalamic hypogonadism vs. polycystic ovary syndrome and compared with normo-ovulatory patients.F S Rep. 2022 Jun 17;3(3):237-245. doi: 10.1016/j.xfre.2022.06.003. eCollection 2022 Sep. F S Rep. 2022. PMID: 36212560 Free PMC article.
-
Polycystic ovarian disease (PCOD)--pregnancy rate and outcome in in vitro fertilization.J Assist Reprod Genet. 1993 Jan;10(1):11-4. doi: 10.1007/BF01204434. J Assist Reprod Genet. 1993. PMID: 8499673 Review. No abstract available.
-
The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.J Assist Reprod Genet. 1997 Jan;14(1):1-4. doi: 10.1007/BF02765740. J Assist Reprod Genet. 1997. PMID: 9013299 Free PMC article. Review.
-
Abnormally activated one-carbon metabolic pathway is associated with mtDNA hypermethylation and mitochondrial malfunction in the oocytes of polycystic gilt ovaries.Sci Rep. 2016 Jan 13;6:19436. doi: 10.1038/srep19436. Sci Rep. 2016. PMID: 26758245 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
